Nine drug makers working on coronavirus vaccines made public commitments on Tuesday to prioritize safety and adhere to rigorous scientific standards in response to mounting political pressure to get a vaccine to market ahead of the November 3rd US presidential election . The pledge was aimed at "building public confidence" by pledging to seek regulatory approval only when enough data was collected from a large phase three study. Three vaccine manufacturers have now entered phase three studies.
Here are some of the biggest developments on Tuesday:
The following data was compiled by Johns Hopkins University:
Global Cases: More than 27.3 million Global Deaths: At least $ 893,200. Cases: More than US 6.30 million. Deaths: At least 189,200